KPMA advocates Vision 2012

Published: 2009-04-02 06:58:00

Updated: 2009-04-02 06:58:00

The Korea Pharmaceutical Manufacturers Association unveiled its plan to expand its annual spending on a range of research and development (R&D) activities to strengthen the country’s growth potential.

Under the program dubbed Vision 2012, the KPMA plans to spend 470 billion won on various R&D ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK